STRUCTURE 润色咨询

STRUCTURE

出版年份：1993 年文章数：2740 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：2.8% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1204376, encodeId=ac5f12043e613, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：结构生物学<br>经验分享：投稿一个月，目前审稿结束，还没有接到下一步通知，不知道接收的概率有多高？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3a52115642, createdName=ms98686908929317181592, createdTime=Sun Mar 20 17:09:35 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098341, encodeId=45251098341e9, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098342, encodeId=eb6d1098342ec, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833504, encodeId=9a3e83350445, content=审稿速度:6.0 | 投稿命中率:5.0<br>经验分享：这个期刊属于cell的子刊，结构生物学的权威期刊！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Sat Aug 27 19:50:02 CST 2016, time=2016-08-27, status=1, ipAttribution=)]
    2022-03-20 ms98686908929317181592

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向：结构生物学
    经验分享：投稿一个月，目前审稿结束，还没有接到下一步通知，不知道接收的概率有多高？

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1204376, encodeId=ac5f12043e613, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：结构生物学<br>经验分享：投稿一个月，目前审稿结束，还没有接到下一步通知，不知道接收的概率有多高？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3a52115642, createdName=ms98686908929317181592, createdTime=Sun Mar 20 17:09:35 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098341, encodeId=45251098341e9, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098342, encodeId=eb6d1098342ec, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833504, encodeId=9a3e83350445, content=审稿速度:6.0 | 投稿命中率:5.0<br>经验分享：这个期刊属于cell的子刊，结构生物学的权威期刊！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Sat Aug 27 19:50:02 CST 2016, time=2016-08-27, status=1, ipAttribution=)]
    2021-12-29 MS54455111222

    讨论中局限性怎么撰写？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1204376, encodeId=ac5f12043e613, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：结构生物学<br>经验分享：投稿一个月，目前审稿结束，还没有接到下一步通知，不知道接收的概率有多高？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3a52115642, createdName=ms98686908929317181592, createdTime=Sun Mar 20 17:09:35 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098341, encodeId=45251098341e9, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098342, encodeId=eb6d1098342ec, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833504, encodeId=9a3e83350445, content=审稿速度:6.0 | 投稿命中率:5.0<br>经验分享：这个期刊属于cell的子刊，结构生物学的权威期刊！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Sat Aug 27 19:50:02 CST 2016, time=2016-08-27, status=1, ipAttribution=)]
    2021-12-27 乌云背后的幸福线

    讨论中一般可以讨论什么？

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1204376, encodeId=ac5f12043e613, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：结构生物学<br>经验分享：投稿一个月，目前审稿结束，还没有接到下一步通知，不知道接收的概率有多高？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3a52115642, createdName=ms98686908929317181592, createdTime=Sun Mar 20 17:09:35 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098341, encodeId=45251098341e9, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098342, encodeId=eb6d1098342ec, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833504, encodeId=9a3e83350445, content=审稿速度:6.0 | 投稿命中率:5.0<br>经验分享：这个期刊属于cell的子刊，结构生物学的权威期刊！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Sat Aug 27 19:50:02 CST 2016, time=2016-08-27, status=1, ipAttribution=)]
    2016-08-27 ms3908193925310106

    审稿速度:6.0 | 投稿命中率:5.0
    经验分享：这个期刊属于cell的子刊，结构生物学的权威期刊！

    0

共6条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分